Eli Lilly Expands U.S. Manufacturing Footprint Eli Lilly (LLY) announced plans to build a $6.5 billion manufacturing facility in Houston, Texas, as the company accelerates its push into obesity and cardiometabolic treatments. The site will focus on producing small molecule